-
Get to know the UCDC researchers: Ben GranBen Gran is the lab manager for both Dr. Rita Basu and Dr.
-
UCDC supports a successful 2025 UAB Endocrinology UpdateHealth care providers from across the state and region gathered to learn about diabetes, thyroid disorders, osteoporosis, and more at the 2025 UAB Endocrinology Update, Aug. 23, at Hilton Birmingham Downtown at the University of Alabama at Birmingham (UAB).
-
UAB diabetes and endocrinology specialty receives high-performing rating by US News & World ReportAccording to the 2025-2026 rankings released in July, UAB Medicine ranked nationally in five adult specialties and high performing in seven other specialties including diabetes and endocrinology.
-
Bril study finds prevalence of MASLD in people with diabetes has decreased in the US, but rates of liver fibrosis are still risingA new study led by UAB Comprehensive Diabetes Center Associate Scientist Fernando Bril, M.D., provides the first evidence that MASLD prevalence is beginning to decrease in adults with diabetes in the U.S. for the first time in decades.
-
UAB startup successfully completes first-in-human study of novel oral diabetes drugThe University of Alabama at Birmingham startup TIXiMED, Inc., has successfully completed a Phase 1 single ascending dose study of the drug TIX100 in humans, marking a key milestone in the development of a first-of-its kind oral therapy for Type 1 diabetes (T1D).
-
UCDC researchers prominently represented in Type 1 diabetes research collectionUAB Comprehensive Diabetes Center (UCDC) researchers have contributed to the Frontiers in Endocrinology Research Topic on Disease-Modifying Approaches in Type 1 Diabetes.
-
Basu appointed to UAB Comprehensive Diabetes Center leadership team as associate directorAnanda Basu, MBBS, MD, FRCP, M.D., has been appointed as an associate director of the UAB Comprehensive Diabetes Center (UCDC) and will play an integral role on the center’s leadership team.
-
UCDC researchers present at 2025 Midwest Islet Club MeetingResearchers from the University of Alabama at Birmingham Comprehensive Diabetes Center (UCDC) showcased their latest findings at the 17th Annual Midwest Islet Club (MIC) Meeting, May 7-8, in Indianapolis, Indiana.
-
Basu study first to use novel glucagon isotopes to measure glucagon metabolism in Type 1 diabetesA new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing tools for further exploration into pancreatic alpha cell function in both Type 1 and 2 diabetes and other metabolic disorders.
-
UAB Pancreatobiliary Disease Center hosts successful second annual Hops & Hope FairThe UAB Pancreatobiliary Disease Center (PDC) hosted the second annual Hops & Hope Fair on Saturday, May 31, 2025 at Cahaba Brewing Company.
-
UAB soars into top 6 percent of global universities in US News rankingsUAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.
-
Blazer Bridge Fund continues encouraging innovative discoveries; announces 2024 winnersBlazer Bridge Fund provides financial support to innovative ideas and inventions by the UAB community, encouraging advanced discovery.
-
Black/African American individuals have an increased risk for severe insulin-deficient diabetesA cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.
-
Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drugThe novel drug TIX100 functions differently from any approved diabetes drug to promote proper islet cell function.
-
UAB Hospital continues to be the best hospital in Alabama, Birmingham metro, according to U.S. News & World ReportFor 11 consecutive years, U.S. News has named UAB Hospital the best hospital in Alabama, with several specialties and procedures ranked among the best.
-
3D in vitro human atherosclerosis model for high-throughput drug screeningThis advance should facilitate atherosclerosis drug discovery and development.
-
Diabetes technology: the future is today, UAB expert saysContinuous glucose monitors and insulin pumps can help patients “live a quality life without burning out on managing diabetes,” said Ananda Basu, M.D., director of the Diabetes Technology Program at UAB.
-
Tackle football season with five diabetes-friendly tailgating tipsUAB diabetes expert serves up tailgating hacks to make football season fun and diabetes-friendly.
-
In Type 1 diabetes, verapamil prevents decline of IGF-1 and promotes beta-cell IGF-1 signalingThese results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1.
-
UAB surpasses 20,000 robotic surgeries milestone, looks to future of continued surgical careIn just the five years since UAB completed 10,000 robotic surgeries, surgeons across 15 disciplines have now collectively exceeded 20,000 robotic surgeries, setting a record for the hospital.
-
What are continuous glucose monitors, and how can they help you?Continuous glucose monitors can transform one’s diabetes treatment and care. A UAB diabetes expert explains what patients should know about the devices when evaluating their diabetes care plans.
-
This diabetes technology is transforming care one meal at a time, expert saysContinuous glucose monitors are “such a useful and impactful behavior modification tool” that half of his patients with Type 1 and Type 2 diabetes now use these devices, said Fernando Ovalle, M.D., director of UAB’s Multidisciplinary Comprehensive Diabetes Clinic. Learn how data leads to better decisions and better control of diabetes.
-
Researcher turns startup founder to pursue promising oral diabetes drugAnath Shalev, M.D., did everything she could to change treatment for Type 1 diabetes from her lab, but getting to first-in-human trials meant taking a step she had always resisted. The most surprising thing about launching a startup, though?
-
UAB ranked in top 8 percent of global universities by U.S. NewsUAB’s research and reputation land it among the top institutions in the world.